End-of-treatment HBsAg, HBcrAg and HBV RNA predict the risk of off-treatment ALT flares in chronic hepatitis B patients

End-of-treatment HBsAg, HBcrAg and HBV RNA predict the risk of off-treatment ALT flares in chronic hepatitis B patients

Background/Purpose(s): Since ALT flares after therapy withdrawal are associated with adverse outcomes, risk stratification is of major importance. We aimed to study whether off-treatment flares are related with virological outcomes, and if serum levels of novel biomarkers at end-of-treatment (EOT) c...

Full description

Bibliographic Details
Main Authors: Sylvia M. Brakenhoff, Robert J. de Knegt, Margo J.H. van Campenhout, Annemiek A. van der Eijk, Willem P. Brouwer, Florian van Bömmel, André Boonstra, Bettina E. Hansen, Thomas Berg, Harry L.A. Janssen, Robert A. de Man, Milan J. Sonneveld
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:Journal of Microbiology, Immunology and Infection
Subjects:
Hepatitis B virus
Serum biomarkers
Liver
HBV
Hepatology
Flare
Online Access:http://www.sciencedirect.com/science/article/pii/S1684118222000937

Internet

http://www.sciencedirect.com/science/article/pii/S1684118222000937

Similar Items